FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.

UCB has received US FDA approval for BIMZELX (bimekizumab-bkzx) to treat adults with three inflammatory conditions.

The EC has granted marketing authorisation to LEO Pharma’s Anzupgo cream for treating adults with moderate to severe chronic ...

Physicians fear use of weight loss drugs in teens will increase or exacerbate eating disorder cases, adding complexity to ...